Rabbit mononuclear leukocytes cause contraction of isolated aorta by the release of serotonin

Cardiovascular Research

Volumn 41, Issue 1, 1999, Pages 246-254

  Hart Favaloro, Joanne L ^a   Woodman, Owen L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Aorta; Leukocyte; Lymphocyte; Monocyte; Rabbit; Serotonin; Vasocontraction

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BOSENTAN; INDOMETACIN; KETANSERIN; PRAZOSIN; SARALASIN; SEROTONIN; SEROTONIN 2 ANTAGONIST;

ANIMAL CELL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SEROTONIN RELEASE;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; AORTA; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CULTURE MEDIA, CONDITIONED; FEMALE; KETANSERIN; LEUKOCYTES, MONONUCLEAR; MALE; PRAZOSIN; RABBITS; SEROTONIN; SEROTONIN ANTAGONISTS; VASOCONSTRICTION;

EID: 0032902848     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00231-4     Document Type: Article

References (38)

1. Clinton SK, Libby P. Cytokines and growth factors in atherogenesis. Arch Pathol Lab Med 1992;116:1292-1300.
2. Lopes-Virella MIF. Atherosclerosis and autoimmunity. Clin Immunol Immunopathol 1994;73:155-167.
3. Zimmennan GA, McIntyre TM, Prescott SM, Otsuka K. Brief review: Molecular mechanisms of neutrophil binding to endothelium involving platelet activating factor and cytokines. J Lipid Mediators 1990;2:S31-S43.
4. Kaul S, Padgett RC, Heistad DD. Role of platelets and leukocytes in modulation of vascular tone. Ann NY Acad Sci 1994;714:122-135.
5. Dale M, Foreman JC. Textbook of immunopharmacology. London: Blackwell Scientific, 1984.
6. Kitazono T, Padgett RC, Armstrong ML, Tompkins PK, Heistad DD. Evidence that angiotensin II is present in human monocytes. Circulation 1995;91:1129-1134.
7. Ehrenreich H, Anderson RW, Fox CH, et al. Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J Exp Med 1990;172:1741-1748.
8. Mugge A, Heistad DD, Padgett RC, et al. Mechanisms of contraction induced by human leukocytes in normal and atherosclerotic arteries. Circ Res 1991;69:871-880.
9. Magazine HI, Andersen TT, Bruner CA, Malik AB. Vascular contractile potency of endothelin-1 is increased in the presence of monocytes or macrophages. Am J Physiol 1994;266:H1620-H1625.
10. Liu JJ, Xie B, Thurlow PJ, Wiley JS, Chen JR. Various cells release a stable small molecule that inhibits endothelium-dependent relaxation. Am J Physiol 1995;269:H1303-H1311.
11. Dusting GJ, Curcio A, Harris PJ, et al. Supersensitivity to vasoconstrictor action of serotonin precedes the development of atheroma-like lesions in the rabbit. J Cardiovasc Pharmacol 1990;16:667-674.
12. Kochanek PM, Hallenbeck IM. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischaemia and stroke. Stroke 1992;23:1367-1379.
13. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993;362:801-809.
14. Docherty I, Constantine I, Starke K. Smooth muscle of rabbit contains alpha 1- but not alpha 2-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 1981;317:5-7.
15. Levesque L, Drapeau G, Grose I, Rioux F, Marceau F. Vascular mode of action of kinin B 1 receptors and development of a cellular model for the investigation of these receptors. Br J Pharmacol 1993;109:1254-1262.
16. Mullane K, Hatala M, Kraemer R, Sessa W, Westlin W. Myocardial salvage induced by REV-5901: an inhibitor and antagonist of the leukotrienes. J Cardiovasc Pharmacol 1987;10:398-406.
17. Marwood JIF, Stokes GS. Vascular smooth muscle serotonin and α-adrenergic receptors. Clin Exp Pharmacol Physiol 1983;10:265-267.
18. Mugge A, Lopez IA, Heistad DD, Lichtlen PR. Vasoconstriction in response to activated leukocytes: implications for vasospasm. Eur Heart J 1993;14:87-92.
19. Lopez JAG, Armstrong ML, Harrison DG, Piegors DI, Heistad DD. Vascular responses to leukocyte products in atherosclerotic primates. Circ Res 1989;65:1078-1086.
20. Faraci FM, Lopez JAG, Breese K, Armstrong ML, Heistad DD. Effect of atherosclerosis on cerebral vascular responses to activation of leukocytes and platelets in monkeys. Stroke 1991;22:790-796.
21. Vanhoutte PM. Vascular effects of serotonin and ischemia. J Cardiovasc Pharmacol 1990;16:S15-S19.
22. Heistad DD, Armstrong ML. Sick vessel syndrome; Can atherosclerotic arteries recover?. Circulation 1994;89:2447-2450.
23. Nakayama K, Ishigai Y, Uchida H, Tanaka Y. Potentiation by endothelin-1 of 5-hydroxytryptamine-induced contraction in coronary artery of the pig. Br J Pharmacol 1991;104:978-986.
24. Vanhoutte PM, Cohen RA, Van Neuten IM. Serotonin and arterial vessels. J Cardiovasc Pharmacol 1984;6:S421-S428.
25. Finocchiaro LME, Nahmod VE, Launay JM. Melatonin biosynthesis and metabolism in peripheral blood mononuclear leukocytes. Biochem J 1991;280:727-731.
26. Mantovani G, Maccio A, Esu S, Lai P. Evidence that cisplatin induces serotonin release from peripheral blood mononuclear cells and that methylprednisolone inhibits this effect. Eur J Cancer 1996;32A:1983-1985.
27. Meyers KM, Holmsen H, Seachford CL. Comparative study of platelet dense granule constituents. Am J Physiol 1982;243:R454-R461.
28. Kaul S, Waack BI, Padgett RC, Brooks RM, Heistad DD. Interaction of human platelets and leukocytes in modulation of vascular tone. Am J Physiol 1994;266:H1706-H1714.
29. 3H]serotonin release. Immunol Lett 1992;32:117-124.
30. Giacovazzo M, Bernoni RM, Di Sabato F, Martelletti P. Impairment of 5-HT binding to lymphocytes and monocytes from tension-type headache patients. Headache 1990;30:220-223.
31. Faraj BA, Olkowski ZL, Iackson RT. Expression of a high-affinity serotonin transporter in human lymphocytes. Int J Immuno-pharmacol 1994;16:561-567.
32. Finocchiaro LME, Arzt ES, Femandez-Castello S, et al. Serotonin and melatonin synthesis in peripheral blood mononuclear cells: Stimulation by interferon-γ as part of an immunomodulatory pathway. J Interferon Res 1988;8:705-716.
33. 1A receptors. Cell Immunol 1990;127:199-214.
34. 1A-type serotonin receptors. Scand J Immunol 1990;32:183-192.
35. Tokamov AA, Kykhova MIP, Koshkina OV, Vasilyev VI. The effect of serotonin on the functional activity of monocytes. Tsitologia 1991;33:81-87.
36. Arzt E, Costas M, Finkielman S, Nahmod VE. Serotonin inhibition of tumour necrosis factor-alpha synthesis by human monocytes. Life Sci 1991;48:2557-2562.
37. 1A receptors regulate a cell contact-mediated interaction between natural killer cells and monocytes. Scand J Immunol 1993;37:7-18.
38. Hellstrand K, Czerkinsky C, Ricksten A, et al. Role of serotonin in the regulation of interferon-gamma production by human natural killer cells. J Interferon Res 1993;13:33-38.